Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Payables (2020 - 2025)

Historic Payables for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $10165.0.

  • BioScience Health Innovations' Payables rose 2033.86% to $10165.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10165.0, marking a year-over-year increase of 2033.86%. This contributed to the annual value of $8226.0 for FY2024, which is 717.92% up from last year.
  • As of Q3 2025, BioScience Health Innovations' Payables stood at $10165.0, which was up 2033.86% from $16636.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Payables high stood at $16636.0 for Q2 2025, and its period low was $760.0 during Q1 2021.
  • Over the past 5 years, BioScience Health Innovations' median Payables value was $8032.0 (recorded in 2023), while the average stood at $7988.4.
  • Over the last 5 years, BioScience Health Innovations' Payables had its largest YoY gain of 166381.58% in 2022, and its largest YoY loss of 7361.7% in 2022.
  • Quarter analysis of 5 years shows BioScience Health Innovations' Payables stood at $10334.0 in 2021, then crashed by 72.26% to $2867.0 in 2022, then surged by 167.7% to $7675.0 in 2023, then grew by 7.18% to $8226.0 in 2024, then rose by 23.57% to $10165.0 in 2025.
  • Its Payables stands at $10165.0 for Q3 2025, versus $16636.0 for Q2 2025 and $16415.0 for Q1 2025.